- Home
- DTE vs WAT Comparison
DTE vs WAT Comparison
Compare DTE & WAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | DTE | WAT |
|---|---|---|
| Founded | 1903 | 1958 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electric Utilities: Central | Biotechnology: Laboratory Analytical Instruments |
| Sector | Utilities | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 28.3B | 23.0B |
| IPO Year | N/A | 1995 |
Fundamental Metrics
Financial Performance| Metric | DTE | WAT |
|---|---|---|
| Price | $128.92 | $377.35 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 11 | 15 |
| Target Price | $149.36 | ★ $388.67 |
| AVG Volume (30 Days) | ★ 1.4M | 544.8K |
| Earning Date | 10-30-2025 | 11-04-2025 |
| Dividend Yield | ★ 3.59% | N/A |
| EPS Growth | N/A | ★ 3.82 |
| EPS | 6.67 | ★ 10.88 |
| Revenue | ★ $14,822,000,000.00 | $3,105,638,000.00 |
| Revenue This Year | $10.64 | $7.96 |
| Revenue Next Year | $4.66 | $6.32 |
| P/E Ratio | ★ $19.46 | $35.43 |
| Revenue Growth | ★ 19.39 | 6.90 |
| 52 Week Low | $116.30 | $275.05 |
| 52 Week High | $143.79 | $423.56 |
Technical Indicators
Market Signals| Indicator | DTE | WAT |
|---|---|---|
| Relative Strength Index (RSI) | 31.32 | 44.84 |
| Support Level | $128.11 | $385.08 |
| Resistance Level | $132.11 | $397.55 |
| Average True Range (ATR) | 1.90 | 9.48 |
| MACD | -0.32 | -3.92 |
| Stochastic Oscillator | 8.89 | 11.90 |
Price Performance
Historical ComparisonAbout DTE DTE Energy Company
DTE Energy owns two regulated utilities in Michigan that contribute 90% of earnings. DTE Electric serves approximately 2.3 million customers in southeastern Michigan, including Detroit. DTE Gas serves 1.3 million customers throughout the state. In addition, DTE has nonutility businesses and investments including energy marketing and trading, renewable natural gas facilities, and on-site industrial energy projects.
About WAT Waters Corporation
Water sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. As a percentage of sales in 2024, Waters generated 58% from biopharmaceutical customers, 31% from industrial clients, and 11% from academic/government institutions. In early 2026, Waters plans to merge with BD's life science and diagnostics business, which will substantially change those concentrations. Waters will wind up with more concentration in diagnostics (versus none now) and discovery-related life science tools.